Enzyme-Sensitive Nanoparticles, Smart TAT and Cetuximab Conjugated Immunoliposomes to Overcome Multidrug Resistance in Breast Cancer Cells

Investigators modified sets of lipids conjugated with cell-penetrating TAT peptide, MMP2 enzyme-sensitive moiety, and cetuximab antibodies against the EGF receptor were synthesized, purified and verified on HPLC, TLC, SEM, and DLS analyses.